NCT04805658Active, not recruiting
Natural History Study of Retinitis Pigmentosa Type 11
Source: ClinicalTrials.gov · Last updated 21 Mar 2025
Brief summary (registry, in English)
Observational study of patients with retinitis pigmentosa type 11
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 16 Mar 2021
- Start date
- Feb 2021
- Primary completion date
- Apr 2028
- Lead sponsor
- Oslo University Hospital
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT04805658
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From Feb 2021 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Under 18 years
- Other types of retinitis pigmentosa
Who the study is looking for
- Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene
- Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Ophthalmology, Oslo University Hospital Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.